Literature DB >> 10858105

Antiretroviral therapy in patients with dual infection with human immunodeficiency virus types 1 and 2.

M Schutten, M E van der Ende, A D Osterhaus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858105     DOI: 10.1056/NEJM200006083422317

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  First-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaboration.

Authors:  Julia Drylewicz; Serge Eholie; Moussa Maiga; Djimon Marcel Zannou; Papa Salif Sow; Didier K Ekouevi; Kevin Peterson; Emmanuel Bissagnene; François Dabis; Rodolphe Thiébaut
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

2.  Virological Characterization of Dual HIV-1/HIV-2 Seropositivity and Infections in Southern Ghana.

Authors:  Kwc Sagoe; Jaa Mingle; Rk Affram; S Britton; A Dzokoto; A Sonnerborg
Journal:  Ghana Med J       Date:  2008-03

3.  Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Authors:  Sabelle Jallow; Abraham Alabi; Ramu Sarge-Njie; Kevin Peterson; Hilton Whittle; Tumani Corrah; Assan Jaye; Matthew Cotten; Guido Vanham; Samuel J McConkey; Sarah Rowland-Jones; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

4.  Varied sensitivity to therapy of HIV-1 strains in CD4+ lymphocyte sub-populations upon ART initiation.

Authors:  Edwin J Heeregrave; Mark J Geels; Elly Baan; Renee M van der Sluis; William A Paxton; Georgios Pollakis
Journal:  AIDS Res Ther       Date:  2010-12-06       Impact factor: 2.250

5.  HIV-2: still off the radar for India's 90-90-90 targets.

Authors:  Priyanka Khopkar-Kale; Smita Kulkarni
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

6.  A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.

Authors:  Geoffrey S Gottlieb; Serge-Paul Eholié; John N Nkengasong; Sabelle Jallow; Sarah Rowland-Jones; Hilton C Whittle; Papa Salif Sow
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

7.  Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2.

Authors:  Andrea Zbinden; Roland Dürig; Cyril Shah; Jürg Böni; Jörg Schüpbach
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.